Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


European Journal of Endocrinology, Vol 132, Issue 1, 103-108
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foresta, C
Right arrow Articles by Rossato, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foresta, C
Right arrow Articles by Rossato, M

Articles

Erythropoietin and testicular steroidogenesis: the role of second messengers

C Foresta, R Mioni, P Bordon, F Gottardello, A Nogara, and M Rossato

Institute of Internal Medicine, University of Padova, Italy.

It has been demonstrated that erythropoietin (EPO) influences rat and human Leydig cell steroidogenesis, stimulating testosterone production through a direct and specific receptor-mediated mechanism. The aim of this study was to investigate the mechanism by which recombinant human erythropoietin (rHuEPO) exerts its stimulatory effect on rat Leydig cells. Recombinant human EPO did not induce, at any dose tested (10(-10) to 10(-13) mol/l), an increase in either cAMP or cGMP, suggesting that in Leydig cells the effect of rHuEPO does not involve the adenylate or guanylate-cyclase systems. The role of transmembrane calcium flux in rHuEPO-stimulated steroidogenesis was studied by evaluating the effect of calcium channel blocker, verapamil, and by the 45Ca2+ uptake method. Verapamil did not influence rHuEPO-induced testosterone secretion and rHuEPO did not modify calcium recycling, indicating that calcium transmembrane flux is not involved in the rHuEPO effect. The protein kinase C inhibitor staurosporine (10, 30, 100 and 300 nmol/l) inhibited rHuEPO-stimulated testicular steroidogenesis in a dose-dependent manner. This indirect evidence suggests that the stimulatory effect of rHuEPO on rat Leydig cells may involve protein kinase C activation.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
D. M. Stocco, X. Wang, Y. Jo, and P. R. Manna
Multiple Signaling Pathways Regulating Steroidogenesis and Steroidogenic Acute Regulatory Protein Expression: More Complicated than We Thought
Mol. Endocrinol., November 1, 2005; 19(11): 2647 - 2659.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Jo, S. R. King, S. A. Khan, and D. M. Stocco
Involvement of Protein Kinase C and Cyclic Adenosine 3',5'-Monophosphate-Dependent Kinase in Steroidogenic Acute Regulatory Protein Expression and Steroid Biosynthesis in Leydig Cells
Biol Reprod, August 1, 2005; 73(2): 244 - 255.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. R. Lappin, A. P. Maxwell, and P. G. Johnston
EPO's Alter Ego: Erythropoietin Has Multiple Actions
Stem Cells, November 1, 2002; 20(6): 485 - 492.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Suzuki, O. Ohneda, S. Takahashi, M. Higuchi, H. Y. Mukai, T. Nakahata, S. Imagawa, and M. Yamamoto
Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality
Blood, September 18, 2002; 100(7): 2279 - 2288.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Magnanti, O. Gandini, L. Giuliani, P. Gazzaniga, H. H. Marti, A. Gradilone, L. Frati, A. M. Agliano, and M. Gassmann
Erythropoietin expression in primary rat Sertoli and peritubular myoid cells
Blood, November 1, 2001; 98(9): 2872 - 2874.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Rossato, A. Nogara, F. Gottardello, P. Bordon, and C. Foresta
Pituitary Adenylate Cyclase Activating Polypeptide Stimulates Rat Leydig Cell Steroidogenesis Through a Novel Transduction Pathway
Endocrinology, August 1, 1997; 138(8): 3228 - 3235.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.